RA Messages for February 15, 2000
PHARMACY PROVIDERS, PLEASE
NOTE!!!
IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG
PRODUCT, PLEASE CONTACT
THE PBM HELP DESK AT 1-800-648-0790
ATTENTION PHARMACY PROVIDERS:
AS A RESULT OF A BUDGETARY SHORTFALL, THE
DEPARTMENT, THROUGH AN EMERGENCY RULE, WILL CHANGE ESTIMATED ACQUISITION COST
REIMBURSEMENT FOR PRESCRIPTION DRUGS TO:
* AVERAGE WHOLESALE MINUS 15% FOR INDEPENDENT PHARMACIES AND
AVERAGE
WHOLESALE PRICE MINUS 16.5% FOR CHAIN PHARMACIES FOR ALL SINGLE
SOURCE DRUGS (BRAND NAME), MULTIPLE SOURCE DRUGS WHICH DO NOT HAVE
A STATE MAXIMUM ALLOWABLE COST OR FEDERAL UPPER LIMIT AND THOSE
PRESCRIPTIONS WHICH ARE SUBJECT TO MAC OVERRIDES BASED ON THE
PHYSICIAN'S CERTIFICATION THAT A BRAND NAME PRODUCT IS MEDICALLY
NECESSARY FOR A PARTICULAR RECIPIENT. THIS REIMBURSEMENT CHANGE IS
EFFECTIVE FOR SERVICES BEGINNING FEBRUARY 1, 2000. CHAIN PHARMACIES
ARE DEFINED AS MORE THAN FIFTEEN MEDICAID ENROLLED PHARMACIES UNDER
COMMON OWNERSHIP. ALL OTHER MEDICAID ENROLLED PHARMACIES ARE
DEFINED AS INDEPENDENT PHARMACIES.
EFFECTIVE FOR DATES OF SERVICE BEGINNING
FEBRUARY 1, 2000, LOUISIANA MEDICAID WILL LIMIT PAYMENTS FOR PRESCRIPTION DRUGS TO THE LOWER
OF:
* ESTIMATED ACQUISITION COST WHICH IS DEFINED AS AVERAGE
WHOLESALE PRICE MINUS 15% FOR INDEPENDENT
PHARMACIES AND AVERAGE WHOLESALE PRICE
MINUS 16.5% FOR CHAIN PHARMACIES FOR ALL SINGLE SOURCE DRUGS (BRAND NAME), MULTIPLE SOURCE DRUGS WHICH DO NOT HAVE A STATE
MAXIMUM ALLOWABLE COST OR FEDERAL UPPER LIMIT AND THOSE PRESCRIPTIONS
WHICH ARE SUBJECT TO MAC OVERRIDES BASED ON THE PHYSICIAN'S
CERTIFICATION THAT A BRAND NAME PRODUCT IS MEDICALLY NECESSARY FOR
A PARTICULAR RECIPIENT PLUS THE MAXIMUM ALLOWABLE OVERHEAD COST (DISPENSING FEE);
* LOUISIANA MAXIMUM ALLOWABLE COST LIMITATION PLUS THE
MAXIMUM ALLOWABLE OVERHEAD COST;
* FEDERAL UPPER LIMIT PLUS THE MAXIMUM ALLOWABLE OVERHEAD
COST; OR
* PROVIDER'S USUAL AND CUSTOMARY CHARGE TO THE GENERAL
PUBLIC.
PLEASE MAKE THE FOLLOWING
CHANGES TO THE 8/15/98 VERSION OF APPENDIX A:
DRUG |
DOSAGE |
STRGTH |
MAC |
EFF.DATE |
BEXAROTENE |
CAPSULE |
75MG |
|
12/29/99 |
BUDESONIDE
|
SPRAY |
32MCG |
|
01/10/00 |
BUSPIRONE HCL
|
TABLET |
30MG |
|
01/19/00 |
DOXERCALCIFEROL |
CAPSULE |
2.5MCG |
|
01/01/00 |
FENOFIBRATE,MICRONIZED |
CAPSULE |
134MG |
|
01/06/00 |
GABAPENTIN |
TABLET |
600MG;800MG |
|
01/10/00 |
GATIFLOXACIN |
TABLET |
400MG |
|
01/19/00 |
MICONAZOLE NITRATE |
COMB.PKG |
1200MG-2% |
|
01/01/00 |
MOXIFLOXACIN |
TABLET |
400MG |
|
12/15/99 |
NEOMYCIN SULF |
TABLET |
500MG |
0.51690 |
02/10/00 |
OLANZAPINE |
TABLET |
15MG |
|
12/06/99 |
OXCARBAZEPINE |
TABLET |
150MG;300MG;600MG |
|
01/17/00 |
PROGESTERONE |
CAPSULE |
200MG |
|
11/01/99 |
RESERPINE |
TABLET |
0.25MG |
0.22389 |
02/10/00 |
PLEASE FILE ADJUSTMENTS FOR CLAIMS WHICH MAY
HAVE BEEN INCORRECTLY PAID.